Dogwood Therapeutics, Inc. (DWTX)
1.12
+0.08
(+7.69%)
USD |
NASDAQ |
Nov 06, 10:07
Dogwood Therapeutics Price to Book Value : 0.5510 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.5116 |
| November 04, 2026 | 0.5067 |
| November 03, 2026 | 0.5116 |
| November 02, 2026 | 0.6001 |
| October 30, 2026 | 0.6296 |
| October 29, 2026 | 0.605 |
| October 28, 2026 | 0.61 |
| October 27, 2026 | 0.5706 |
| October 26, 2026 | 0.546 |
| October 23, 2026 | 0.5509 |
| October 22, 2026 | 0.5509 |
| October 21, 2026 | 0.5755 |
| October 20, 2026 | 0.5657 |
| October 19, 2026 | 0.5952 |
| October 16, 2026 | 0.6001 |
| October 15, 2026 | 0.6149 |
| October 14, 2026 | 0.6247 |
| October 13, 2026 | 0.6395 |
| October 12, 2026 | 0.6739 |
| October 09, 2026 | 0.6887 |
| October 08, 2026 | 0.6936 |
| October 07, 2026 | 0.7034 |
| October 06, 2026 | 0.7477 |
| October 05, 2026 | 0.7477 |
| October 02, 2026 | 0.7182 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.7034 |
| September 30, 2026 | 0.6641 |
| September 29, 2026 | 0.6641 |
| September 28, 2026 | 0.669 |
| September 25, 2026 | 0.669 |
| September 24, 2026 | 0.7034 |
| September 23, 2026 | 0.7428 |
| September 22, 2026 | 0.7428 |
| September 21, 2026 | 0.787 |
| September 18, 2026 | 0.8313 |
| September 17, 2026 | 0.8461 |
| September 16, 2026 | 0.8362 |
| September 15, 2026 | 0.851 |
| September 14, 2026 | 0.9076 |
| September 11, 2026 | 0.9543 |
| September 10, 2026 | 0.9248 |
| September 09, 2026 | 0.9543 |
| September 08, 2026 | 1.004 |
| September 04, 2026 | 1.126 |
| September 03, 2026 | 1.161 |
| September 02, 2026 | 1.220 |
| September 01, 2026 | 1.294 |
| August 31, 2026 | 1.269 |
| August 28, 2026 | 1.304 |
| August 27, 2026 | 1.141 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.756 |
| Alnylam Pharmaceuticals, Inc. | 5.852 |
| Anika Therapeutics, Inc. | 1.638 |
| Savara, Inc. | 6.534 |
| Vericel Corp. | 7.116 |
Price to Book Value Related Metrics
| Price | 1.12 |
| Earnings Yield | -799.1% |
| Market Cap | 37.67M |